Central Drugs Standard Control Organization's Subject Expert Committee has suggested emergency use authorisation for Remdesivir tablets by Jubliant life Sciences, according to a report by ANI quoting sources.
SEC suggests emergency use authorisation for Remdesivir tablets by Jubliant life Sciences: Sources